A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults

Exclusion Criteria

• •1. HCV genotype or subtype other than GT1b.
• •2. Positive test result for Hepatitis B surface antigen (HbsAg) or confirmed positive anti-HIV antibody (HIV Ab) test.
• •3. Any current or past clinical evidence of cirrhosis.
• •4. Screening laboratory analyses that shows abnormal results.
• •5. Clinically significant abnormalities or co-morbidities, other than HCV infection that make the participant an unsuitable candidate for this study.